Abstract:INTRODUCTION:Components of the metabolic syndrome are highly prevalent in chronic kidney disease (CKD) patients--some of which paradoxically appear to predict an improved outcome in this population. We hypothesized that the circulating calcification inhibitor fetuin-A/AHSG, which is also a natural inhibitor of the tyrosine kinase insulin receptor, could be one factor explaining the association between increased fat mass and a survival advantage in CKD and thus conducted an explorational study to provide preliminary data to support further research into this hypothesis. PATIENTS AND METHODS:In a cross-sectional study, we evaluated 198 CKD stage 5 patients (GFR 6.8 +/- 0.2 ml/min; 62% males, mean age 52 +/- 1 years) close to the start of renal replacement therapy. We studied circulating AHSG (ELISA) and two common functional AHSG gene polymorphisms (at amino acids Thr248Met (C-T) and Thr256Ser (C-G) using Pyrosequencing) and related these to multiple components of the metabolic syndrome. RESULTS:Median circulating AHSG was lower (p < 0.01) in type-2 (0.22 g/l) and type-1 (0.16 g/l) diabetics as compared to non-diabetic CKD-5 patients (0.24 g/l). AHSG correlated with both total and truncal fat mass in type-2 diabetics (rho 0.37 and 0.39; p < 0.001, respectively), but not in type-1 diabetics or non-diabetics. Both SNPs significantly influenced circulating levels of AHSG, and were also associated with significant differences in serum triglycerides and HDL cholesterol. Furthermore, there were significant differences in the prevalence of metabolic syndrome criteria between the AHSG Thr256Ser (C-G) genotype groups, with a more atherogenic lipid profile in AHSG high producers (Thr/Thr homozygotes). In multivariate analysis, the association between circulating AHSG and fat mass remained significant also after adjustment for age, gender, inflammation (CRP >10 mg/l), and AHSG genotype. CONCLUSIONS:The present, explorational, study supports further, mechanistic, studies into a physiological link between AHSG and body fat mass in patients with CKD. As we observed an association between higher fat mass and elevated AHSG levels, these preliminary results may form the basis of further study to establish if the observed associations may be one reason why obesity has been reported to constitute a survival advantage in CKD.

Tu-P7:117 An endothelial cell retention study on tissue engineered vascular grafts

[Relationship of Tumor Necrosis Factor Gene Polymorphism and Acute Graft-Versus-host Disease after Unrelated Allogeneic Hematopoietic Stem Cell Transplantation].

Association of AHSG gene polymorphisms and aortic stiffness in peritoneal dialysis patients

Alpha 2‐heremans‐schmid Glycoprotein Gene Polymorphism (rs4918) is Associated with Coronary Artery Calcification in Incident Peritoneal Dialysis Patients

Polymorphisms in the Promoter Region of the Angiotensinogen Gene Are Associated with Liver Cirrhosis in Patients with Chronic Hepatitis B.

Is Fetuin-A/Alpha 2-Heremans-schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease?

Polymorphisms In The Vegfa Promoter Are Associated With Susceptibility To Hepatocellular Carcinoma By Altering Promoter Activity

Single Nucleotide Polymorphisms in Promoter of Angiotensin II Type 1 Receptor Gene Associated with Essential Hypertension and Coronary Heart Disease in Chinese Population.

Abstract 11643: ACTN4 Regulates HLA-DPA1-Related Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension Through Allele-Specific Binding to Functional SNP rs9277336

Genetic Variation Of The Human Alpha-2-Heremans-Schmid Glycoprotein (Ahsg) Gene Associated With The Risk Of Sars-Cov Infection

A Novel GJA5 Variant Associated with Increased Risk of Essential Hypertension

Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese.

Heredity of Endothelin Secretion

The TGFB1 Functional Polymorphism rs1800469 and Susceptibility to Atrial Fibrillation in Two Chinese Han Populations

Heredity Of Endothelin Secretion - Human Twin Studies Reveal The Influence Of Polymorphism At The Chromogranin A Locus, A Novel Determinant Of Endothelial Function

Role of GSPT1 and GSPT2 Polymorphisms in Different Outcomes Upon Hepatitis B Virus Infection and Prognosis to Lamivudine Therapy.

A1166c Genetic Variation of the Angiotensin Ii Type I Receptor Gene and Susceptibility to Coronary Heart Disease: Collaborative of 53 Studies with 20,435 Cases and 23,674 Controls

Polymorphisms in the SAA1 gene are associated with ankle-to-brachial index in Han Chinese healthy subjects.

Single Neucleotide Polymorphisms of the Vascular Endothelial Growth Factor Gene in Chinese Han Population

[Study on correlation between single nucleotide polymorphism in promotor of hepatic lipase gene and nontraumatic avascular necrosis of femoral head]

The A98V Single Nucleotide Polymorphism (SNP) in Hepatic Nuclear Factor 1 α (<i>HNF-1</i>α) is Associated with Insulin Sensitivity and β-Cell Function